AddLife (ALIF) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
14 Dec, 2025Executive summary
Achieved strong organic and acquired growth, with EBITA/EBITDA margin rising to 11.1% from 9.8% year-over-year, and significant profit improvements supported by cost control and lower interest rates.
Net sales for Q3 reached SEK 2,429m (+4% YoY), with organic growth at 6% and acquired growth at 1%.
Profit before tax increased 164% and profit after tax surged 228% year-over-year, with EPS at SEK 0.66.
Net debt/EBITDA reduced to 2.9, meeting the target of below 3.0 and enabling increased acquisition activity.
Platform acquisitions in Europe and a focus on advanced, high-margin products have strengthened segment performance and margins.
Financial highlights
EBITA/EBITDA grew 17–20% year-over-year, with EBITA margin at 11.1% (9.8% last year) and year-to-date margin at 11.9% (11.0%).
Profit after tax for Q3 was SEK 82m (+228% YoY); EPS SEK 0.66.
Operating cash flow for Q3 was SEK 145m; accumulated operating cash flow SEK 504m (429m last year).
Cash conversion remained above 90%, with a focus on working capital efficiency.
Net debt decreased by SEK 52m in Q3.
Outlook and guidance
Inventory increased in preparation for expected strong Q4 sales.
Strengthened balance sheet and reduced leverage enable increased acquisition activity.
Continued focus on profitability improvement and efficiency initiatives, with positive long-term market outlook.
Latest events from AddLife
- High margins, strong organic growth, and acquisitions drive robust performance and outlook.ALIF
Q1 202629 Apr 2026 - Profitability and margins improved, debt reduced, and outlook for 2026 is strong.ALIF
Q4 20254 Feb 2026 - Q2 2024 delivered 8% sales and 21% EBITA growth, with improved cash flow and a key acquisition.ALIF
Q2 20243 Feb 2026 - 3% organic growth, stable margins, and cost savings support a strong Q4 outlook.ALIF
Q3 202419 Jan 2026 - Q4 organic growth, margin gains, and cash flow drive higher dividend and positive 2025 outlook.ALIF
Q4 20246 Jan 2026 - Margin and cash flow gains, debt reduction, and new acquisition drive positive outlook.ALIF
Q1 202521 Dec 2025 - Margins and profit surged, led by Labtech, with strong cash flow and a positive M&A outlook.ALIF
Q2 202515 Jul 2025